Gene expression analysis has shown ENO2 mRNA to be elevated in breast cancer lymph node metastases compared to primary breast tumors [33] and ENO2 mRNA to be upregulated in the estrogen receptor positive subset of 36 invasive ductal breast carcinomas [34]. Here, ENO2 is linked to invasive ductal breast carcinoma.